Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause SW, Bethge W, Jost E, Platzbecker U, Klein SA, Schubert J, Niederland J, Kaufmann M, Schäfer-Eckart K, Schaich M, Baldauf H, Stölzel F, Petzold C, Röllig C, Alakel N, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Bornhäuser M, Mikesch JH, Schetelig J; Study Alliance Leukemia and the German Cooperative Transplant Study Group. Stelljes M, et al. Among authors: baldauf h. Lancet Haematol. 2024 May;11(5):e324-e335. doi: 10.1016/S2352-3026(24)00065-6. Epub 2024 Apr 4. Lancet Haematol. 2024. PMID: 38583455 Free article. Clinical Trial.
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Middeke JM, Kollinger F, Baldauf H, Stölzel F, Wermke M, von Bonin M, Sockel K, Link CS, Teipel R, Röllig C, Thiede C, Platzbecker U, Ehninger G, Bornhäuser M, Schetelig J. Middeke JM, et al. Among authors: baldauf h. Biol Blood Marrow Transplant. 2018 Sep;24(9):1947-1951. doi: 10.1016/j.bbmt.2018.05.021. Epub 2018 May 21. Biol Blood Marrow Transplant. 2018. PMID: 29793046 Free article.
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails.
Schetelig J, Baldauf H, Heidenreich F, Massalski C, Frank S, Sauter J, Stelljes M, Ayuk FA, Bethge WA, Bug G, Klein S, Wendler S, Lange V, de Wreede LC, Fürst D, Kobbe G, Ottinger HD, Beelen DW, Mytilineos J, Fleischhauer K, Schmidt AH, Bornhäuser M. Schetelig J, et al. Among authors: baldauf h. Blood. 2020 Apr 16;135(16):1386-1395. doi: 10.1182/blood.2019002887. Blood. 2020. PMID: 31932846 Free PMC article.
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study.
Schetelig J, Hoek J, Stilgenbauer S, Middeke JM, Andersen NS, Fox CP, Lenhoff S, Volin L, Shimoni A, Schroyens W, van Gelder M, Bunjes D, van Biezen A, Baldauf H, de Wreede LC, Tournilhac O, Kröger N, Yakoub-Agha I, Dreger P. Schetelig J, et al. Among authors: baldauf h. Bone Marrow Transplant. 2021 Mar;56(3):692-695. doi: 10.1038/s41409-020-01013-y. Epub 2020 Aug 16. Bone Marrow Transplant. 2021. PMID: 32801318 Free PMC article. No abstract available.
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M. Schetelig J, et al. Among authors: baldauf h. Front Immunol. 2021 Jan 19;11:584520. doi: 10.3389/fimmu.2020.584520. eCollection 2020. Front Immunol. 2021. PMID: 33542712 Free PMC article.
CCR5Δ32 mutations do not determine COVID-19 disease course.
Bernas SN, Baldauf H, Wendler S, Heidenreich F, Lange V, Hofmann JA, Sauter J, Schmidt AH, Schetelig J. Bernas SN, et al. Among authors: baldauf h. Int J Infect Dis. 2021 Apr;105:653-655. doi: 10.1016/j.ijid.2021.02.108. Epub 2021 Mar 2. Int J Infect Dis. 2021. PMID: 33667698 Free PMC article.
Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study.
Schetelig J, Hoek J, Stilgenbauer S, Middeke JM, Andersen NS, Fox CP, Lenhoff S, Volin L, Shimoni A, Schroyens W, van Gelder M, Bunjes D, van Biezen A, Baldauf H, de Wreede LC, Tournilhac O, Kröger N, Yakoub-Agha I, Dreger P. Schetelig J, et al. Among authors: baldauf h. Bone Marrow Transplant. 2022 Jan;57(1):144. doi: 10.1038/s41409-021-01524-2. Bone Marrow Transplant. 2022. PMID: 34773090 Free PMC article. No abstract available.
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation.
Sarraf AA, Schetelig J, Baldauf H, Stölzel F, Middeke JM, Sockel K, Teipel R, Brückner S, Berning M, Zeissig S, Babatz J, Baretton GB, Hampe J, Bornhäuser M, Aust D, Schmelz R. Sarraf AA, et al. Among authors: baldauf h. Exp Hematol. 2022 Apr;108:36-45. doi: 10.1016/j.exphem.2022.01.005. Epub 2022 Jan 13. Exp Hematol. 2022. PMID: 35033627 Free article.
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
Sockel K, Stölzel F, Hönl F, Baldauf H, Röllig C, Wermke M, von Bonin M, Teipel R, Link-Rachner C, Brandt K, Kroschinsky F, Hänel M, Morgner A, Klesse C, Ehninger G, Platzbecker U, Bornhäuser M, Schetelig J, Middeke JM. Sockel K, et al. Among authors: baldauf h. Cancer Manag Res. 2022 Feb 15;14:547-559. doi: 10.2147/CMAR.S339846. eCollection 2022. Cancer Manag Res. 2022. PMID: 35210852 Free PMC article.
Reanalysis of unclear CMV status results from buccal swab samples of potential stem cell donors is an efficient donor registry strategy.
Bernas SN, Behrens GA, Baldauf H, Baier DM, Fischer H, Pruschke J, Heidenreich F, Ruhner K, Hofmann JA, Markert J, Schetelig J, Lange V, Schmidt AH. Bernas SN, et al. Among authors: baldauf h. Transpl Immunol. 2022 Dec;75:101729. doi: 10.1016/j.trim.2022.101729. Epub 2022 Oct 14. Transpl Immunol. 2022. PMID: 36252924 Free article.
70 results